Skip to content
An Initiative of AVAC
Search
Back to Country Data

Country Overview:
Zimbabwe

Global PrEP Tracker
Last Updated: 19 June 2025

Drug Registration Status

Approved
Pending
Not
Approved
Lenacapavir (LEN) for PrEP — Gilead
Data Not Available
Cabotegravir (CAB) for PrEP — ViiV
Approved 2022 2022
Dapivirine Vaginal Ring (DVR) — Pop Council
Approved 2021 2021
Oral PrEP TDF/FTC — Gilead (Truvada)
Approved 2017 2017
Oral PrEP TDF/xTC* - generic
Approved
Oral PrEP F/TAF — Gilead
Not Approved
* TDF/xTC refers to tenofovir disoproxil fumarate (TDF) and either emtricitabine (FTC) or lamivudine (3TC)

Research, Demonstration and Implementation

Oral PrEP

7 Completed Projects

Dapivirine Vaginal Ring

4 Planned/Ongoing Projects

Injectable PrEP

4 Planned/Ongoing Projects

Policy Frameworks

Implementation Plan for HIV Pre-Exposure Prophylaxis in Zimbabwe, 2018-2020

Zimbabwe National HIV/AIDS Strategic Plan, 2021–25

Guidelines for HIV Prevention, Testing, and Treatment in Zimbabwe, 2022

Est. Cumulative
Initiations:

Total PrEP: 337,010

Oral PrEP: 334,499

Dapivirine Vaginal Ring: 858

Injectable PrEP: 1,653

Where To Access PrEP in Zimbabwe:

HIV Care Now

Featured Resources

Document

Zimbabwe Strategic Direction Summary, 2023

The US President’s Emergency Plan for AIDS Relief (PEPFAR) Zimbabwe interagency team collaborated with key partners including the Government of Zimbabwe (GoZ), the Global Fund to Fight AIDS, Tuberculosis and Malaria (GFATM), civil society organizations (CSOs), and other bilateral and multilateral health development partners to develop the 2023 Country Operational Plan (COP23) for FY 2024/25.…
Document

CAB PrEP Introduction Situation Analysis – Zimbabwe – 2023

This document summarizes findings from the national situation analysis that can support the creation of a national biomedical HIV prevention platform. It aims to clarify critical steps for the introduction of biomedical HIV prevention products.
Document

Zimbabwe National HIV Communications Strategy, 2019-25

Zimbabwe has taken the first step towards integrating health in various different sectors by making this Communications Strategy less program centered and more client centered. With the recognition that people seek various different types of healthcare, this Communication Strategy highlights the needs of various different populations and delivers the tools that programmers, funders, and implementing…
Document

Stakeholder conversations to inform delivery of new HIV prevention methods in Zimbabwe

A readout of conversations with local stakeholders about the dapivirine vaginal ring, looking to gain insight on implementation considerations from providers and potential end-users.
Document

Dapivirine Ring Early Introduction Considerations — Zimbabwe Analysis

The OPTIONS Consortium conducted secondary research and interviews with key stakeholders in several countries to understand questions about the ring that could inform demonstration and processes for introducing new biomedical HIV prevention products. Zimbabwe was prioritized for analysis due to the state of the HIV epidemic in the country and experience with ring trials. (For…
Document

Key Population Manual for Healthcare Providers, 2018

Stigma towards vulnerable populations often leaves them unable to access HIV health messages and services. This training works to raise awareness amongst healthcare providers regarding their own biases as a means to remove barriers to healthcare access for the vulnerable populations.
Presentation

Health Care Workers’ Knowledge, Attitudes, and Practices Related to Oral PrEP Provision to Adolescent Girls and Young Women in Zimbabwe

Conclusions from the study: knowledge of oral PrEP is high among providers; training should explore providers’ discomfort with certain population groups, such as married adolescent girls and young women; and training should emphasize nonjudgmental services.
Document

PMM Landscape Analysis, Malawi & Zimbabwe (2020)

PMM is advancing planning for future biomedical prevention product introductions, with a focus on CAB-LA, to avoid oral PrEP challenges and reduce time to impact. PMM used quantitative and qualitative methods to identify sub-national geographies, target populations, delivery channels, and prevention networks to prioritize in early introduction activities for CAB-LA.
View All Resources